Beacon Medical Interchange
Avatar

Are TMB and Nivolumab/Ipilimumab Ready for Clinical Use? Insights from CheckMate 227

By Beacon Medical Interchange FEATURING Jack West
By Beacon Medical Interchange FEATURING Jack West
490 views
November 2, 2018
Dr. Jack West considers whether the results from the CheckMate 227 trial comparing nivolumab/ipilimumab to ...
read more ↘
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
18:47
Total Health

Updates in the Management of NSCLC: Systemic Therapy Year in Review

Feat. W. Iams
17:34
ecancer

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

Feat. L. Raez
07:38
GRACE

How Does PD-L1 Score Affect Treatment Options for NSCLC

Feat. S. Patel, T. Leal, P. Iyengar, A. Desai, C. Kim, J. Rotow
20:28
OncoAlert

mNSCLC Updates: 1L EGFRm, 2/3L EGFRm & Anti-Trop2 ADC

Feat. C. Aggarwal
10:34
GRACE

ASCO® 2023 Insights: "CheckMate 9LA 4-Year Follow-Up - Chemo + …

Feat. J. West, C. Lovly, A. Addeo
07:13
Insights from 2023 WCLC

WCLC 2023 Insights: "5-Year Survival of Pembro + Chemo for mNSC…

Feat. S. Gadgeel
13:01
Nebraska Oncology Society

ASCO 2022 on Immunotherapy Updates in Advanced NSCLC

Feat. J. Brahmer
12:26
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

2024 Neuro-Oncology Update: NSCLC and Brain Mets

Feat. T. McGranahan
06:53
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "RAMOSE Trial - Osimertinib+/-Ramucirumab i…

Feat. X. Le
18:14
Janakiraman Subramanian

Understanding KRAS G12C Positive Lung Cancer

10:29
NYU Langone

FDA Approval of Adagrasib in KRAS G12Cm NSCLC

Feat. J. Sabari
12:16
ecancer

ASCO® 2023 Summary: "Analysis of Key Studies in Lung Cancer - A…

Feat. L. Raez
33:37
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Fred Hutchinson Cancer Center Review of Metastatic NSCLC

Feat. C. Baik
04:14
ecancer

ASCO® 2023 Insights: "Phase 3 LUNAR Study - Tumor Treating Fiel…

Feat. T. Leal
21:35
Total Health

Management of Advanced NSCLC: IO, Targeted Therapy, and Beyond

Feat. T. Patil
14:26
Memorial Sloan Kettering Cancer Center

Radiation for Unresectable NSCLC: Where Are We Now and Where Are We …

Feat. D. Gomez
14:33
ILCC 2022 Conference Coverage

1L Single Agent Immunotherapy for mNSCLC

Feat. A. Chiang
04:29
GRACE

Dual Immune Checkpoint Blockade With or Without Chemotherapy for mNS…

Feat. C. Kim
14:11
Lorenzo Belluomini

Selpercatinib in RET Fusion-Positive mNSCLC: Achievements and Gray A…

21:04
2022 West Oncology Conference

Metastatic NSCLC: Approaches and Updates

Feat. J. Porter